James Ashall is a Senior Virologist at Pfizer, specializing in the development of anti-viral therapeutics for both acute and chronic viral infections. Previously, they served as a Postdoctoral Researcher at the London School of Hygiene and Tropical Medicine, where they investigated Dengue virus transmission. James has also worked as a Scientist for the Medicines and Healthcare products Regulatory Agency, focusing on diagnostic controls for emerging viral infections. They hold a PhD in Virology from the same institution and are currently pursuing an MSc in Infectious Diseases.
Location
United Kingdom
Links
This person is not in the org chart
This person is not in any teams
This person is not in any offices